Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
about
Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics SimulationsChemical Variations on the p53 Reactivation ThemeTargeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer TherapyTargeting Oncogenic Mutant p53 for Cancer TherapyRecent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterizationExploring the role of receptor flexibility in structure-based drug discoverySmall molecule compounds targeting the p53 pathway: are we finally making progress?Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescueDisulfide isomerase-like protein AtPDIL1-2 is a good candidate for trichlorophenol phytodetoxificationEmerging Computational Methods for the Rational Discovery of Allosteric Drugs.Parameter choice matters: validating probe parameters for use in mixed-solvent simulations.Molecular dynamics simulations: from structure function relationships to drug discovery.Exploration of the conformational landscape in pregnane X receptor reveals a new binding pocketBeyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties.Exploring the mechanism of F282L mutation-caused constitutive activity of GPCR by a computational study.Targeting tumor suppressor networks for cancer therapeutics.Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseasesBenzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design.Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.Discovery of Novel Isatin-Based p53 InducersSmall-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory AxisConformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 EctodomainDrug repurposing to target Ebola virus replication and virulence using structural systems pharmacology.Glutamine Synthetase Drugability beyond Its Active Site: Exploring Oligomerization Interfaces and Pockets.Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.HIV-1 Protease Dimerization Dynamics Reveals a Transient Druggable Binding Pocket at the Interface.Genetic and functional analysis of a Li Fraumeni syndrome family in China.Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding.RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response.Pharmacological reactivation of p53 as a strategy to treat cancer.TP53: an oncogene in disguise.Combining experimental and simulation data of molecular processes via augmented Markov models.Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.A Kepler Workflow Tool for Reproducible AMBER GPU Molecular Dynamics.Structural Evolution and Dynamics of the p53 Proteins.Full-length p53 tetramer bound to DNA and its quaternary dynamics.Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors.Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domain.Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53.
P2860
Q26747130-576A94F7-CBEE-4D63-8DAF-EA150D1DBAA6Q26749008-543A33D8-B032-4CEA-A323-66B56AAB5E68Q26766341-62E02FD3-AC32-4D10-BE87-9A722E568258Q26770856-EFD31FEC-4CE7-4520-B113-5D2BE7039B1DQ26996528-C151BA82-EDE1-4B1E-A897-257CDE88E121Q27001129-8E293FE7-9982-4C79-A16A-02F150590E0FQ27027835-3A8D3180-4281-42F6-BA14-F6E896D7180BQ27680171-2FB0F309-2328-47DE-86D0-902E9C75E9D6Q28817953-F71247D5-A37B-439F-A4EC-510109861FC4Q30358225-FE0A69B7-8727-4144-9798-2D4F7E2D17E0Q30365087-DB2F165F-7438-4C37-BD65-2A15591BDD64Q30369875-F0A7433B-E79D-4DE7-A1B1-841A7E228AB8Q30391745-45EACD3A-8B5A-4983-AA5E-0026FAA562C5Q30392142-1CECB448-1E37-47A8-B6BF-F19E44915CCDQ30394046-E1CB5644-180A-4CC1-874F-8474E4EAA7A0Q33657519-C63A1A86-1AED-4889-9C0D-CB4C997B6E24Q33909288-A5DDF70C-897D-4A28-B8BE-95316A6093E3Q33915380-CD791E15-2D11-4461-A796-A66F271C80A9Q35063635-A14E4BC1-A275-474D-A9F2-E4D4DF80B4E3Q35750496-8AD50713-100A-4A3B-9973-346AF4788348Q35759870-5A284164-605D-4A1C-9DA3-680C4A44B2AFQ35886682-CA5E461F-32D6-4BB1-8A57-D5B37A3BDA82Q35926542-2F9C1242-F7E6-4B74-AD48-4797767D15BEQ36100472-7932A426-A124-4A1B-A322-72F2AE1A9CB3Q36198159-C5E3F8F3-73FF-498C-99B1-3A09A03949AAQ36392939-44EBB0E9-37B3-4B91-9804-C81F51D00485Q36512100-0099AB1A-4BB3-43BC-98A8-6D91E873C9C6Q37207524-DDC0604E-F02A-4F45-8399-2785284AC37BQ38147113-9FB57A29-D010-45EF-BFD9-12B4E1BCD7C3Q38286198-BB4D1CAE-2174-4397-89A1-DFE4E629FD3FQ38507513-DB5A9433-909D-4FE7-B28F-2AE373F1C52EQ38674854-A0E57BDF-CBD0-4DBA-95A2-DEF0C63155ECQ38675922-051BD03C-FF0A-4CDB-859F-E379C2CEE6BAQ38715489-68AFED33-33FE-4FE6-B296-8FDEBCE3AE67Q38811603-348675D3-5E3E-4D7F-9ACD-FD270EFFFD65Q38820037-E4642C77-3783-4E65-BF54-BCA7345052F0Q38934098-3249312F-97BB-4177-9B96-5B7BE841B20EQ39152860-1CEFA799-9E49-4C75-9BCF-68E354A07DBFQ39673538-10ECA9FA-0270-4498-A864-FE5BBBD19FF1Q40242926-BA3AF885-F57B-4CA1-8F6B-60B65B5CDDC3
P2860
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Computational identification o ...... for reactivation of mutant p53
@ast
Computational identification o ...... for reactivation of mutant p53
@en
Computational identification o ...... for reactivation of mutant p53
@nl
type
label
Computational identification o ...... for reactivation of mutant p53
@ast
Computational identification o ...... for reactivation of mutant p53
@en
Computational identification o ...... for reactivation of mutant p53
@nl
prefLabel
Computational identification o ...... for reactivation of mutant p53
@ast
Computational identification o ...... for reactivation of mutant p53
@en
Computational identification o ...... for reactivation of mutant p53
@nl
P2093
P2860
P3181
P356
P1476
Computational identification o ...... for reactivation of mutant p53
@en
P2093
A Richard Chamberlin
Benjamin P Chung
Brad D Wallentine
Chiung-Kuang Chen
Christopher D Wassman
Da-Wei Lin
Faezeh Salehi
G Wesley Hatfield
Hartmut Luecke
Linda V Hall
P2860
P2888
P3181
P356
10.1038/NCOMMS2361
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1009779547